AERES Biomedical Ltd. · London United Kingdom
| 1-3 Burtonhole Lane, Mill Hill | Phone: +44-20-8906-7222 |
| London | Fax: +44-20-8906-7201 |
| NW7 1AD | |
| United Kingdom | 
Map This Company |
AERES Biomedical Ltd. Rankings
Company Description
AERES Biomedical develops therapeutic antibodies. The biopharmaceutical research company has developed more than 20 antibody candidates though collaborative partnerships with other biotech and pharmaceutical companies, many of which are in clinical trial stages. ABC-48 (an antibody for the treatment of deep vein thrombosis) and ABC-120 (an antibody for treating malaria) are two of the company's top candiates. AERES' products target debilitating and life-threatening illnesses, such as infectious, inflamatory, and cardiovascular diseases. The company was founded in 1999.
AERES Biomedical Ltd. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateSingle Location |
|---|---|
| Fiscal Year-End | March |
Executives
6 executives listed for AERES Biomedical Ltd.'s London, United Kingdom location.
| Chairman | David Owen | |
|---|---|---|
| CEO and Chief Scientific Officer | Tarran Jones | |
| COO and CFO | David Copsey |